Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study

Objective: To determine the safety and efficacy of PRC-063, a once-daily, multilayer, extended-release (ER) formulation of methylphenidate (MPH) hydrochloride, in the treatment of attention-deficit/hyperactivity disorder (ADHD) in children in a randomized, double-blind, parallel group, dose-optimize...

Descripción completa

Detalles Bibliográficos
Autores principales: Childress, Ann C., Brams, Matthew N., Cutler, Andrew J., Donnelly, Graeme A.E., Bhaskar, Sailaja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757528/
https://www.ncbi.nlm.nih.gov/pubmed/33090921
http://dx.doi.org/10.1089/cap.2020.0109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757528/
https://www.ncbi.nlm.nih.gov/pubmed/33090921
http://dx.doi.org/10.1089/cap.2020.0109

Ejemplares similares